Author:
Dahan Arik,Sabit Hairat,Amidon Gordon L.
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. S. R. Orenstein, D. A. Gremse, C. D. Pantaleon, D. F. Kling, and K. S. Rotenberg. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: An open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin. Ther. 27:472 (2005).
2. M. Sasaki, T. Sudoh, and A. Fujimura. Pharmacokinetics of ranitidine and nizatidine in very elderly patients. Am. J. Ther.
12:223–225 (2005).
3. M. Feldman, and M. Burton. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 2. N. Engl. J. Med.
323:1749–1755 (1990).
4. M. Feldman, and M. Burton. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1. N. Engl. J. Med. 323:1672–1680 (1990).
5. M. P. Knadler, R. F. Bergstrom, J. T. Callaghan, and A. Rubin. Nizatidine, an H2-blocker. Its metabolism and disposition in man. Drug Metab. Dispos. 14:175–182 (1986).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献